Repligen (RGEN) Net Income towards Common Stockholders Growth (1y) (2011 - 2026)
Repligen (RGEN) Net Income towards Common Stockholders Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 23.94% |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | -34.15% |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 0.98% |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | -58.26% |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 16.64% |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 3.33% |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | -188.83% |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 38.46% |
| 10 | Repligen | 10.25 Bn | 9.24 Bn | 110.04 Mn | -66.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -66.31% |
| Mar 31, 2026 | 43.60% |
| Dec 31, 2025 | 129.69% |
| Sep 30, 2025 | 2,379.97% |
| Jun 30, 2025 | 160.21% |
| Mar 31, 2025 | 76.93% |
| Dec 31, 2024 | -1,435.78% |
| Sep 30, 2024 | -103.86% |
| Jun 30, 2024 | -71.13% |
| Mar 31, 2024 | -88.57% |
| Dec 31, 2023 | -82.68% |
| Sep 30, 2023 | -58.12% |
| Jun 30, 2023 | -60.32% |
| Mar 31, 2023 | -39.12% |
| Dec 31, 2022 | 67.40% |
| Sep 30, 2022 | 20.62% |
| Jun 30, 2022 | 37.61% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 344.22% |
| Sep 30, 2021 | 130.20% |